will be very interesting, they have found the same cohort in Australia with similar conditions as they had success in US cohort (this is very hard to find), looks like they will have similar outcome as the promising results from U.S. cohorts which included complete responses in patients who failed prior treatments, they will continue to recruit more and we may have a lot of these news from today to March or April and news relating to US cohorts.. lets see when will shorting crowd gets fatigued by all the share sacrifices they are doing to keep the share price down and accumulators scaring the retails to give up their shares..
IMU Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)